Songporn Oranratnachai

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Metastatic Colorectal Cancer

Top Venues

Cancer medicine

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Danainut Naratornsirakul, Busayamas Chewaskulyong, Sarawut Kongkarnka, Songporn Oranratnachai
Comparison of treatment outcome between first-line combination immunotherapy (anti-PD-L1 or anti-PD1) with or without chemotherapy and chemotherapy alone in advanced non-small cell lung cancer patients in tertiary care hospital. Cancer medicine 13 (14) (2024)
Danainut Naratornsirakul, Busayamas Chewaskulyong, Sarawut Kongkarnka, Songporn Oranratnachai
Comparison of treatment outcome between first-line combination immunotherapy (anti-PD-L1 or anti-PD1) with or without chemotherapy and chemotherapy alone in advanced non-small cell lung cancer patients in tertiary care hospital. Cancer medicine 13 (14) (2024)
Danainut Naratornsirakul, Busayamas Chewaskulyong, Sarawut Kongkarnka, Songporn Oranratnachai
Comparison of treatment outcome between first-line combination immunotherapy (anti-PD-L1 or anti-PD1) with or without chemotherapy and chemotherapy alone in advanced non-small cell lung cancer patients in tertiary care hospital. Cancer medicine 13 (14) (2024)
Songporn Oranratnachai, Sasivimol Rattanasiri, Ekaphop Sirachainan, Amarit Tansawet, Nilubol Raunroadroong, Gareth J McKay, John Attia, Ammarin Thakkinstian
Treatment outcomes of advanced hepatocellular carcinoma in real-life practice: Chemotherapy versus multikinase inhibitors. Cancer medicine (2022)
Songporn Oranratnachai, Watchalawalee Yamkaew, Atchara Tunteeratum, Thongchai Sukarayothin, Nareenart Iemwimangsa, Ravat Panvichien
Characteristics of breast cancer patients tested for germline BRCA1/2 mutations by next-generation sequencing in Ramathibodi Hospital, Mahidol University. Cancer reports (Hoboken, N.J.) (2022)